Hans von Celsing

Hans von Celsing has held various roles in the corporate world since 1998. Hans began as the Owner of Berkshire Invest in 1998 and then went on to become Director of Mevion Medical Systems in 2008 and Director of Sonowand A/S in 2010. In the same year, they were appointed Executive Chairman of BiOxyDyn Ltd. Hans also became Chairman of the Board for Gelexir Healthcare Ltd in 2012, Partner Fondkommission AB in 2013, Peptonic Medical AB in 2016, and CLS AB in 2010, where they also served as a Member of the Board of Directors. Most recently, they were appointed Non Executive Director of Advanced Oncotherapy plc in 2017.

Hans von Celsing attended the Stockholm School of Economics from 1971 to 1974, where they earned a Civilekonom degree. Hans then attended Harvard Business School from 1976 to 1978, where they earned a Master of Business Administration (MBA).